Do the existing staging systems for primary liver cancer apply to combined hepatocellular carcinoma-intrahepatic cholangiocarcinoma?

被引:0
|
作者
Qiang Zhou [1 ]
Hao Cai [1 ]
Ming-Hao Xu [1 ]
Yao Ye [2 ]
Xiao-Long Li [1 ]
Guo-Ming Shi [1 ]
Cheng Huang [1 ]
Xiao-Dong Zhu [1 ]
Jia-Bin Cai [1 ]
Jian Zhou [1 ]
Jia Fan [1 ]
Yuan Ji [2 ]
Hui-Chuan Sun [1 ]
Ying-Hao Shen [1 ]
机构
[1] Department of Liver Surgery,Liver Cancer Institute,Zhongshan Hospital,and Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education),Fudan University
[2] Department of Pathology,Zhongshan Hospital,Fudan University
基金
上海市自然科学基金;
关键词
D O I
暂无
中图分类号
R735.7 [肝肿瘤];
学科分类号
100214 ;
摘要
Background:The incidence of combined hepatocellular carcinoma-intrahepatic cholangiocarcinoma(c HCC-ICC) is relatively low,and the knowledge about the prognosis of c HCC-ICC remains obscure.In the study,we aimed to screen existing primary liver cancer staging systems and shed light on the prognosis and risk factors for c HCC-ICC.Methods:We retrospectively reviewed 206 c HCC-ICC patients who received curative surgical resection from April 1999 to March 2017.The correlation of survival measures with the histological types or with tumor staging systems was determined and predictive values of tumor staging systems with c HCC-ICC prognosis were compared.Results:The histological type was not associated with overall survival(OS)(P = 0.338) or disease-free survival(DFS)(P = 0.843) of patients after curative surgical resection.BCLC,TNM for HCC,and TNM for ICC stages correlated with both OS and DFS in c HCC-ICC(all P < 0.05).The predictive values of TNM for HCC and TNM for ICC stages were similar in terms of predicting postoperative OS(P = 0.798) and DFS(P = 0.191) in c HCC-ICC.TNM for HCC was superior to BCLC for predicting postoperative OS(P = 0.022) in c HCC-ICC.Conclusion:The TNM for HCC staging system should be prioritized for clinical applications in predicting c HCC-ICC prognosis.
引用
收藏
页码:13 / 20
页数:8
相关论文
共 50 条
  • [41] LIVER TRANSPLANTATION FOR INTRAHEPATIC CHOLANGIOCARCINOMA (ICC) AND COMBINED HEPATOCELLULAR-CHOLANGIOCARCINOMA (CHCC-CC)
    Rodriguez de Lope, C.
    Colmenero, J.
    Miquel, R.
    Forner, A.
    Rimola, J.
    Reig, M.
    Navasa, M.
    Bruix, J.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S261 - S261
  • [42] Two case reports of breast cancer combined with synchronous primary intrahepatic cholangiocarcinoma/mixed liver cancer
    Tan, Miduo
    Luo, Liu
    Wang, Taoli
    Zhang, Zhiyong
    Wei, Yuqin
    Long, Chenyan
    MEDICINE, 2024, 103 (48)
  • [43] HEPATITIS-C VIRUS-ANTIBODY IN PATIENTS WITH PRIMARY LIVER-CANCER (HEPATOCELLULAR-CARCINOMA, CHOLANGIOCARCINOMA, AND COMBINED HEPATOCELLULAR-CHOLANGIOCARCINOMA) IN JAPAN
    TOMIMATSU, M
    ISHIGURO, N
    TANIAI, M
    OKUDA, H
    SAITO, A
    OBATA, H
    YAMAMOTO, M
    TAKASAKI, K
    NAKANO, M
    CANCER, 1993, 72 (03) : 683 - 688
  • [44] HEPATITIS-C VIRUS-ANTIBODY IN PATIENTS WITH PRIMARY LIVER-CANCER (HEPATOCELLULAR-CARCINOMA, CHOLANGIOCARCINOMA, AND COMBINED HEPATOCELLULAR-CHOLANGIOCARCINOMA) IN JAPAN
    OZYILKAN, E
    OZYILKAN, O
    FIRAT, D
    TELATAR, H
    CANCER, 1994, 73 (07) : 2002 - 2003
  • [45] Differentially expressed gene profiles of intrahepatic cholangiocarcinoma, hepatocellular carcinoma, and combined hepatocellular-cholangiocarcinoma by integrated microarray analysis
    Xue, Tong-Chun
    Zhang, Bo-Heng
    Ye, Sheng-Long
    Ren, Zheng-Gang
    TUMOR BIOLOGY, 2015, 36 (08) : 5891 - 5899
  • [46] Tobacco smoking, alcohol use and risk of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: The Liver Cancer Pooling Project
    Petrick, Jessica Leigh
    Campbell, Peter T.
    Koshiol, Jill
    Thistle, Jake E.
    Andreotti, Gabriella
    Beane-Freeman, Laura E.
    Buring, Julie E.
    Chan, Andrew T.
    Chong, Dawn Q.
    Doody, Michele M.
    Gapstur, Susan M.
    Gaziano, John Michael
    Giovannucci, Edward
    Graubard, Barry I.
    Lee, I-Min
    Liao, Linda M.
    Linet, Martha S.
    Palmer, Julie R.
    Poynter, Jenny N.
    Purdue, Mark P.
    Robien, Kim
    Rosenberg, Lynn
    Schairer, Catherine
    Sesso, Howard D.
    Sinha, Rashmi
    Stampfer, Meir J.
    Stefanick, Marcia
    Wactawski-Wende, Jean
    Zhang, Xuehong
    Zeleniuch-Jacquotte, Anne
    Freedman, Neal D.
    McGlynn, Katherine A.
    CANCER RESEARCH, 2017, 77
  • [47] Imaging features of combined hepatocellular and cholangiocarcinoma compared with those of hepatocellular carcinoma and intrahepatic cholangiocellular carcinoma in a Chinese population
    Wang, Y.
    Yang, Q.
    Li, S.
    Luo, R.
    Mao, S.
    Shen, J.
    CLINICAL RADIOLOGY, 2019, 74 (05) : 407.e1 - 407.e10
  • [48] Primary liver cancer: Intrahepatic cholangiocarcinoma emerges from the shadows
    Tsai S.
    Nathan H.
    Pawlik T.M.
    Updates in Surgery, 2010, 62 (1) : 5 - 9
  • [49] Liver transplantation for combined hepatocellular carcinoma and cholangiocarcinoma: A multicenter study
    Kim, Jongman
    Joo, Dong-Jin
    Hwang, Shin
    Lee, Jeong-Moo
    Ryu, Je-Ho
    Nah, Yang-Won
    Kim, Dong-Sik
    Kim, Doo-Jin
    You, Young-Kyoung
    Yu, Hee-Chul
    WORLD JOURNAL OF GASTROINTESTINAL SURGERY, 2023, 15 (07): : 1340 - 1353